TP53 and cancer: Adenoviruses ONYX‐015, which has a deletion in the portion of E1B that inactivates p53, are currently investigated in a phase I trial in combination with etanercept (a recombinant dimer of the human TNF); so far, this study enrolled two patients with metastatic breast cancer, as well as other patients with different types of cancer [92].